Cargando…

Development of key performance indicators for renal replacement therapy in adult intensive care to guide safe and cost-effective therapy

Detalles Bibliográficos
Autores principales:	Fischer, A, Finney, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069565/ http://dx.doi.org/10.1186/cc13586

Ejemplares similares

Renal replacement therapy for acute renal failure in the intensive care unit is associated with a worse prognosis than renal replacement therapy for end-stage renal failure
por: Ostermann, M, et al.
Publicado: (2005)

Renal replacement therapy and bloodstream infections in cardiovascular intensive care patients
por: Strabelli, TMV, et al.
Publicado: (2006)

Intensive insulin therapy and indications for intensive care admission
por: Sanusi, A, et al.
Publicado: (2007)

Long-term renal and survival outcomes in acute kidney injury patients receiving renal replacement therapy in intensive care
por: Elsayed, I, et al.
Publicado: (2015)

Is the AKIN score useful as an indicator of the optimum time for intervention with renal replacement therapy in critically ill patients?
por: Mousdale, S, et al.
Publicado: (2012)

Protein losses in continuous renal replacement therapies
por: Rodigues, MG, et al.
Publicado: (2005)

Provision of intermittent renal replacement service outside an ICU is safe and effective
por: Wilton, P, et al.
Publicado: (2008)

Amino acid adherence in continuous renal replacement therapies
por: Rodrigues, MG, et al.
Publicado: (2005)

Fluid balance and renal outcomes in patients requiring renal replacement therapy in the ICU
por: Silversides, JA, et al.
Publicado: (2013)

Sustained low-efficiency dialysis for renal replacement therapy in the ICU: a cost-benefit analysis of the years 2006 to 2010
por: Neuenfeldt, T, et al.
Publicado: (2012)

Antimicrobial resistance in bloodstream infection does not affect outcome in intensive care unit patients with acute renal failure treated with renal replacement therapy
por: Hoste, E, et al.
Publicado: (2005)

Hypercalcemia during renal replacement therapy after liver transplantation
por: Matsumi, J, et al.
Publicado: (2011)

Continuous renal replacement therapy: are we getting the dose right?
por: Martin, S, et al.
Publicado: (2010)

Renal replacement therapy in very elderly critical care patients
por: Brown, K, et al.
Publicado: (2014)

Extracorporeal renal replacement therapy in patients with heparin-induced thrombocytopenia
por: Bekers-Anchipolovskis, M, et al.
Publicado: (2009)

Stability of citrate and calcium dosing in citrate renal replacement therapy
por: Sadaat, F, et al.
Publicado: (2015)

Tedizolid clearance by in vitro continuous renal replacement therapy model
por: Lewis, SJ, et al.
Publicado: (2015)

Micronutrient loss in renal replacement therapy for acute kidney injury
por: Oh, W, et al.
Publicado: (2015)

Evaluation of the clinical effectiveness of a computerised decision-supported intensive insulin therapy regimen
por: Shulman, R, et al.
Publicado: (2007)

An audit of antibiotic dosing according to renal function or renal replacement therapy in critical care
por: Donnelly, KD, et al.
Publicado: (2011)

Incidence and outcome of acute renal failure necessitating renal replacement therapy after trauma
por: Beitland, S, et al.
Publicado: (2009)

Determinants of renal recovery and mortality inpatients undergoing continuous renal replacement therapy in the ICU
por: Gleeson, PJ, et al.
Publicado: (2015)

Protein losses and nitrogen balance during continuous renal replacement therapy
por: Hayami, H, et al.
Publicado: (2011)

Metabolic disturbances encountered during pediatric continuous renal replacement therapy
por: Soysal, D, et al.
Publicado: (2006)

Outcome of patients treated with renal replacement therapy for acute kidney injury
por: Desegher, A, et al.
Publicado: (2006)

Influence of veno-venous renal replacement therapy on transpulmonary thermodilution measurements
por: Sakka, S, et al.
Publicado: (2006)

Removal of inflammatory mediators by continuous renal replacement therapy in severe sepsis
por: Tomas, E, et al.
Publicado: (2009)

Fluid accumulation post cardiac surgery and risk for renal replacement therapy
por: Moore, EM, et al.
Publicado: (2014)

Recovery of renal function after acute kidney injury requiring continuous renal replacement therapy
por: Jung, HY, et al.
Publicado: (2014)

Use of 2-hourly creatinine clearance to inform cessation of renal replacement therapy
por: Solymos, O, et al.
Publicado: (2011)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Infection in ICU patients with acute kidney injury treated with renal replacement therapy
por: Reynvoet, E, et al.
Publicado: (2006)

Previous renal support is a predictor for chronic renal replacement therapy after orthotopic liver transplantation
por: Andreoli, MCC, et al.
Publicado: (2011)

Intensive insulin therapy-associated costs differ substantially between ICUs
por: Harmsen, RE, et al.
Publicado: (2011)

Procalcitonin to guide length of antibiotic therapy in surgical intensive care patients
por: Schroeder, S, et al.
Publicado: (2008)

Evaluation of microcirculation before and during continuous renal replacement therapy and the impact of dose prescription
por: Pipili, C, et al.
Publicado: (2012)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

Optimal dose of renal replacement therapy in acute kidney injury: a meta-analysis
por: Van Wert, RJ, et al.
Publicado: (2009)

Initiation of renal replacement therapy in patients with acute kidney injury and severe lactic acidosis
por: Vuylsteke, S, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_kg2hkbiin36ddmtsa6rlhb6a8l